aTYR PHARMA INC Annual Weighted Average Number of Shares Outstanding, Diluted from 2020 to 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
aTYR PHARMA INC quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2024.
  • aTYR PHARMA INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 74.3M shares, a 38.5% increase year-over-year.
  • aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 74.3M shares, a 38.5% increase from 2023.
  • aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 53.6M shares, a 88.6% increase from 2022.
  • aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 28.4M shares, a 48.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 74.3M +20.7M +38.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 53.6M +25.2M +88.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 28.4M +9.34M +48.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-13
2021 19.1M +9.92M +108% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 9.16M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.